MELANIE MCGILLOWAY: Open Payments
NPI 1366921322 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,501 in 24 payments from 11 companies in 2025. Trend: 2023 $18,667 · 2024 $5,824 · 2025 $1,501
Food & beverage: $1,401Education: $100
| Company | Payments | Amount |
|---|---|---|
| Ferring Pharmaceuticals Inc. | 5 | $405 |
| Janssen Biotech, Inc. | 9 | $345 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $150 |
| AstraZeneca Pharmaceuticals LP | 2 | $121 |
| Astellas Pharma US Inc | 1 | $115 |
| Boston Scientific Corporation | 1 | $113 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $105 |
| Janssen Scientific Affairs, LLC | 1 | $65 |
| Procept Biorobotics Corporation | 1 | $38 |
| Teleflex LLC | 1 | $23 |
Products named: ADSTILADRIN, RYBREVANT, ERLEADA, Nubeqa, Padcev, Axonics, PYLARIFY, LYNPARZA.
Industry payments across CA — which companies pay providers there.
